(Health-NewsWire.Net, August 26, 2016 ) With the ageing population and the increased incidence of cardiovascular diseases, current gold standard anticoagulants have become unable to satisfy the treatment demand. It is inevitable for improved drugs to come into the market. Warfarin and heparin which have monopolized the anticoagulant market for over half a century will gradually be replaced by the new generation of direct thrombin inhibitor and Xa factor inhibitor and finally fade out. Request sample at : https://marketreportscenter.com/request-sample/133421
The representative varieties of thrombin are as follows: hirudin, recombinant hirudin, bivalirudin, argatroban and dabigatran etexilate. Direct thrombin inhibitor brought in a sales value of USD 2.4 billion in 2013, ranking third among anti-clotting drugs. And it occupied 10.4% of the total sales value of anti-clotting drugs while dabigatran etexilate accounted for 73.6% of the sum. According to CRIs survey, the sales value of thrombin in China rose from CNY 13 million in 2005 to CNY 20.77 million in 2014 with CAGR during this period reaching about 5.6%. Currently, major manufacturers of thrombin in the Chinese market are Changchun Guoao Pharmaceutical Co., Ltd, Biochemical Pharmaceutical Factory of Zhuhai S. E. Z., Hunan Yige Pharmaceutical Co., Ltd, Hacon Pharma and Wuxi Kaifu Pharmaceutical Co., Ltd. With the change of life styles and ageing population, the incidence of cardiovascular disease is expected to keep increasing in the next few years in China, driving the market size of thrombin to expand further.
Check for Discount at : https://marketreportscenter.com/request-discount/133421 Readers can get at least the following information from this report: -market size of thrombin in China -competitive landscape of thrombin in Chinese market -price of thrombin made by different enterprises in China -market outlook of thrombin in China
The author suggests the following groups of people purchase this report: -manufacturers of anticoagulants -investors/ research institutions interested in Chinese medicine market -any interest in the Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133421/investigation-report-on-china-thrombin-market-2010-2019
Connect for more details: Sam Collins Market Reports Center Call us : 1-646-883-3044 (US) Email : info@marketreportscenter.com visit our website : https://marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com
|